イリノイ州における卵巣がんの臨床試験
イリノイ州内の拠点で、卵巣がんに関する49件の研究が参加者を募集しています。
イリノイ州内の都市
- Chicago36件の研究
- Peoria7件の研究
- Evanston7件の研究
- Waukegan6件の研究
- Cicero6件の研究
- Aurora5件の研究
- Arlington Heights5件の研究
- Joliet4件の研究
- Champaign4件の研究
- Springfield4件の研究
- Naperville4件の研究
- Decatur3件の研究
- Bloomington3件の研究
- Danville3件の研究
- Charleston3件の研究
- Elgin3件の研究
公式研究テキスト（英語）
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Advocate Good Shepherd Hospital, Barrington
- Illinois CancerCare-Bloomington, Bloomington
- Illinois CancerCare-Canton, Canton
- 他57件
被験者募集中第2相
全年齢 · 全性別 · 2026/10/02更新 · NCT05564377A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- University of Chicago Hospital, Chicago
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06465069A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- University of Illinois Cancer Center, Chicago
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06172478A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
- University of Chicago Medical Center /ID# 278295, Chicago
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07278336A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
- Rush Md Anderson Cancer Center /ID# 274926, Chicago
- University of Chicago Medical Center /ID# 274796, Chicago
- OSF St. Francis Medical Center /ID# 274752, Peoria
- 他1件
被験者募集中第2相
18歳以上 · 女性 · 2026/09/29更新 · NCT06890338Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
- University of Chicago, Chicago
被験者募集中観察研究
18歳以上 · 女性 · 2026/09/29更新 · NCT05051722A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
- University of Chicago Medical Center, Chicago
被験者募集中第1/2相
18歳以上 · 女性 · 2026/09/24更新 · NCT04590326A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- Illinois Cancer Specialists, Arlington Heights
- Northwestern Memorial Hospital, Chicago
- Rush University Medical Center, Chicago
- 他2件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07213804Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Northwestern University Feinberg School of Medicine, Chicago
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/21更新 · NCT05983432A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
- City of Hope, Chicago, Zion
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/17更新 · NCT07109726A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
- Illinois Cancer Specialists (ICS) ( Site 8009), Arlington Heights
被験者募集中第3相
18歳以上 · 女性 · 2026/09/17更新 · NCT07318558Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- The University of Chicago Medicine, Chicago
- Carle Cancer Center, Effingham
- Northshore University Health System-Evanston Hospital, Evanston
- 他1件
被験者募集中第3相
18歳以上 · 女性 · 2026/09/15更新 · NCT07214779Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
- University of Chicago, Chicago
被験者募集中第2相
18歳以上 · 女性 · 2026/09/14更新 · NCT06787612Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
- University of Illinois Cancer Center, Chicago
- University of Chicago Medicine, Chicago
- City of Hope - Chicago, Zion
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/10更新 · NCT06293898Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- University of Chicago, Chicago
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/08更新 · NCT04107077Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
- University of Chicago Medical Center, Chicago
被験者募集中第1相
15歳以上 · 全性別 · 2026/08/25更新 · NCT06276491Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Lurie Children's Hospital-Chicago, Chicago
被験者募集中第1/2相
12 Months – 30 Years · 全性別 · 2026/08/25更新 · NCT04851119Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
- Northwestern University, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
- Northwestern Medicine Cancer Center Old Irving Park, Chicago
- 他5件
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/08/19更新 · NCT07001748A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
- St. Francis Medical Center (OSF Healthcare), Peoria
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/18更新 · NCT07470853A Study of PHST001 in Advanced Solid Tumors
- University of Chicago Medical Center, Chicago
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/12更新 · NCT06840886Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
- Research Site, Chicago
被験者募集中第1/2相
18歳〜130歳 · 全性別 · 2026/08/12更新 · NCT05417594A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
- Advocate Outpatient Center - Aurora, Aurora
- Advocate Good Shepherd Hospital, Barrington
- Carle BroMenn Outpatient Center, Bloomington
- 他35件
被験者募集中
35歳〜50歳 · 女性 · 2026/08/07更新 · NCT04251052Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- OSF Saint Anthony's Health Center, Alton
- Rush-Copley Medical Center, Aurora
- Advocate Outpatient Center - Aurora, Aurora
- 他58件
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/07更新 · NCT06580314Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
- St. Francis Medical Center (OSF Healthcare), Peoria
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/05更新 · NCT07444814A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Orchard Healthcare Research Inc, Skokie
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/05更新 · NCT06330064A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Hope and Healing Cancer Services, Hinsdale
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/30更新 · NCT04657068A Trial to Evaluate Safety, Tolerability, and Preliminary Efficacy of Misetionamide (GP-2250) as Monotherapy or in Combination With Gemcitabine
- Rush University Medical Center, Chicago
被験者募集中第1相
18歳以上 · 女性 · 2026/07/23更新 · NCT03854110Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer
- The University of Chicago Medical Center, Chicago
被験者募集中第2相
18歳以上 · 女性 · 2026/07/21更新 · NCT04918186An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib
- Northwestern Memorial Hospital, Chicago
被験者募集中第2相
18歳〜100歳 · 女性 · 2026/07/13更新 · NCT05887609A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- Ingalls Family Care Center, Calumet City
- UChicago Medicine - River East, Chicago
- The University Of Chicago, Chicago
- 他13件
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/06更新 · NCT04389632Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
- Endeavor Health Evanston Kellogg Cancer Care Center, Evanston
被験者募集中第3相
18歳以上 · 女性 · 2026/07/02更新 · NCT06819007Integrated Cancer Repository for Cancer Research
- Rush-Copley Cancer Care Center, Aurora
- Rush-Copley Healthcare Center, Yorkville
被験者募集中観察研究健康なボランティア歓迎
19歳〜110歳 · 全性別 · 2026/06/29更新 · NCT02012699A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
- Northwestern University, Chicago
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/06/29更新 · NCT05377996A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
- GSK Investigational Site, Harvey
被験者募集中第2相
18歳以上 · 全性別 · 2026/06/24更新 · NCT04641247A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
- Northwestern Memorial Hospital, Chicago
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/06/04更新 · NCT04300556Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
- Northwestern University, Chicago
被験者募集中
60歳以上 · 女性 · 2026/05/29更新 · NCT05743517Study of NMS-03305293 in Adult Patients With Relapsed Ovarian Cancer
- OSF Saint Francis Medical Center, Peoria
被験者募集中第1相
18歳以上 · 女性 · 2026/05/28更新 · NCT06930755ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
- University of Chicago Medical Center, Chicago
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/05/13更新 · NCT03686124TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
- UChicago Medicine, Chicago
被験者募集中
25歳〜50歳 · 女性 · 2026/04/06更新 · NCT04294927ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。